NPM1 and acute myeloid leukemia: SSZ combined with the anthracycline daunorubicin (DNR) exhibits a significant synergistic effect in vitro, and it also enhances DNR/Ara‐C anti‐leukaemic activity in NPM1‐mutated AML primary samples and a patient‐derived xenograft (PDX) model [73].